the

Abstract and Open World Partner to Launch the First National-Scale Tokenization Engine for the World’s Most Valuable Real-World Assets

For the first time, the world's most strategic assets—AI supercomputing centers, strategic real estate and critical energy assets—are crossing the…

2 hours ago

VELO AND THE McLAREN FORMULA 1 TEAM’S FAN-DESIGNED LIVERY TAKES CENTRE STAGE AS LANDO NORRIS WINS 2025 DRIVERS’ CHAMPIONSHIP IN ABU DHABI

ABU DHABI, UAE, Dec. 8, 2025 /PRNewswire/ -- Yesterday, the McLaren Formula 1® Team's Lando Norris celebrated his first ever Drivers'…

2 hours ago

The Acceleration Continues: Vetty Named One of Nucleus Researchs Hot Companies to Watch in 2026

AUSTIN, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Vetty, the one-stop shop hiring acceleration platform, announced today that it was…

5 hours ago

Global Stars Confirmed as the Games of the Future Abu Dhabi 2025 Finalises Full Line-Up

Some of the biggest names in phygital sports and esports from around the world will head to Abu Dhabi for…

6 hours ago

The 4th China International Supply Chain Expo Set for Beijing in June 2026

Sustained Worldwide Outreach Drives Greater Collaboration OpportunitiesBEIJING, Dec. 7, 2025 /PRNewswire/ --  The 4th China International Supply Chain Expo ("CISCE,"…

16 hours ago

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…

19 hours ago

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

December 07, 2025 16:00 ET  | Source: Wave Life Sciences USA, Inc. CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) --…

19 hours ago

TScan Therapeutics Announces Positive Updated Data from the ALLOHA Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

December 06, 2025 17:30 ET  | Source: TScan Therapeutics, Inc. Treatment arm continues to demonstrate favorable relapse-free survival (HR=0.50; p=0.23)…

2 days ago

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

December 06, 2025 17:30 ET  | Source: Fulcrum Therapeutics, Inc. ― Clear dose-response observed, with a robust and clinically meaningful…

2 days ago

Blokees exhibits at CCXP25 in Brazil: World Premiere of the New Saint Seiya Product

SHANGHAI, Dec. 6, 2025 /PRNewswire/ -- From December 4 to 7, Assembly Character Toys brand Blokees made its first debut…

2 days ago